EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ergothioneine Attenuates Oxaliplatin-Induced Peripheral Neuropathy Without Compromising Antitumor Efficacy

Takumu Yamada, Takumi Iwasawa iD, Ryohma Tsuchiya, Tomoaki Ito iD, Kazunori Kato

International Journal of Molecular Sciences · 22.10.2025 · 26 (21) · 10263

DOI: 10.3390/ijms262110263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.10.2025. Verfasst von Takumu Yamada und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Graduate School of Science and Engineering, Toyo University, Saitama 350-8585, Japan. Hauptthemen laut MEDLINE: Ergothioneine, Oxaliplatin, Peripheral Nervous System Diseases, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, Toyo University Top Priority Research Program, The Promotion and Mutual Aid Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer remains one of the leading causes of cancer-related mortality both in Japan and worldwide. Oxaliplatin (L-OHP) is a key chemotherapeutic agent used in the treatment of colorectal and other malignancies; however, its clinical use is often limited by the development of oxaliplatin-induced peripheral neuropathy (OIPN). In this study, we investigated ergothioneine (EGT), a natural antioxidant abundant in mushrooms, for its potential to mitigate OIPN without compromising the antitumor efficacy of L-OHP. Using the SH-SY5Y neuroblastoma cell line and differentiated neurons, we assessed the effects of EGT on L-OHP-induced apoptosis, oxidative stress, and axonal degeneration. We further evaluated whether EGT interferes with the anticancer activity of L-OHP using cultured cancer cell lines and a tumor-bearing mouse model. EGT suppressed L-OHP-induced apoptosis in neuronal cells and preserved axonal structures in differentiated neurons. Importantly, EGT had no adverse effect on the antitumor efficacy of L-OHP, as evidenced by unchanged cancer cell proliferation, tumor volume, and body weight in treated mice. These findings suggest that EGT may be a promising adjuvant for preventing OIPN while maintaining the therapeutic benefits of L-OHP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErgothioneineOxaliplatinPeripheral Nervous System DiseasesAntineoplastic AgentsAnimalsHumansMiceCell Line, TumorApoptosisOxidative StressAntioxidantsXenograft Model Antitumor AssaysColorectal NeoplasmsCell ProliferationMaleNeurons

Stichwörter der Autor:innen

colorectal cancerergothioneineoxaliplatinoxaliplatin-induced peripheral neuropathy (OIPN)

Substanzen

ErgothioneineOxaliplatinAntineoplastic AgentsAntioxidants

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Graduate School of Science and Engineering, Toyo University, Saitama 350-8585, Japan.
  • Institution of Life Innovation Studies, Toyo University, Tokyo 115-8650, Japan.
  • Shizuoka Medical Research Center for Disaster, Juntendo University Shizuoka Hospital, Shizuoka 410-2295, Japan.
  • Department of Surgery, Juntendo University Shizuoka Hospital, Juntendo University School of Medicine, Shizuoka 410-2295, Japan.
  • Department of Nutrition Sciences, Graduate School of Health and Sports Sciences, Toyo University, Tokyo 115-8650, Japan.

ORCID-Profile: Takumi Iwasawa, Tomoaki Ito

Förderung

  • JSPS KAKENHI
  • Toyo University Top Priority Research Program
  • The Promotion and Mutual Aid Corporation
  • Grant-in-Aid for the Enryo Inoue Memorial

Zitieren

APA

Yamada, T., Iwasawa, T., Tsuchiya, R., Ito, T., & Kato, K. (2025). Ergothioneine Attenuates Oxaliplatin-Induced Peripheral Neuropathy Without Compromising Antitumor Efficacy. International Journal of Molecular Sciences, 26(21), 10263. https://doi.org/10.3390/ijms262110263

Vancouver

Yamada T, Iwasawa T, Tsuchiya R, Ito T, Kato K. Ergothioneine Attenuates Oxaliplatin-Induced Peripheral Neuropathy Without Compromising Antitumor Efficacy. International Journal of Molecular Sciences. 2025;26(21):10263. doi:10.3390/ijms262110263

BibTeX
@article{Yamada2025,
  author = {Yamada, Takumu and Iwasawa, Takumi and Tsuchiya, Ryohma and Ito, Tomoaki and Kato, Kazunori},
  title = {Ergothioneine Attenuates Oxaliplatin-Induced Peripheral Neuropathy Without Compromising Antitumor Efficacy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {21},
  pages = {10263},
  doi = {10.3390/ijms262110263}
}
Kostenlos starten →